{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:05:31Z","timestamp":1789725931381,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hroo.2026.05.023","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:47:20Z","timestamp":1780642040000},"page":"1613-1620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individualized dose\u2013response algorithm vs weight-based heparin dosing for intraprocedural anticoagulation during atrial fibrillation ablation"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8614-052X","authenticated-orcid":false,"given":"Jared Bryce","family":"Pleash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael David","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuppence","family":"Richman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Cumpston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.Y.","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2026.05.023_bib1","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/615087","article-title":"Early heparin administration reduces risk for left atrial thrombus formation during atrial fibrillation ablation procedures","author":"Asbach","year":"2011","journal-title":"Cardiol Res Pract 2011"},{"key":"10.1016\/j.hroo.2026.05.023_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10840-008-9270-x","article-title":"Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation","volume":"22","author":"Bruce","year":"2008","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hroo.2026.05.023_bib3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.hrthm.2014.03.003","volume":"11","author":"Di Biase","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2026.05.023_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.05.023_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105422","article-title":"Factors other than body weight predicting heparin loading to acquire optimal activated clotting time in endovascular neurointerventions","volume":"184","author":"Oshita","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.hroo.2026.05.023_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/europace\/euaa199","article-title":"Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial","volume":"23","author":"Hohnloser","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.05.023_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/jcm9020350","article-title":"Activated clotting time monitoring during atrial fibrillation catheter ablation: does the anticoagulant matter?","volume":"9","author":"Martin","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.hroo.2026.05.023_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12872-021-02032-3","article-title":"Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hroo.2026.05.023_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40261-016-0435-6","article-title":"Adequate initial heparin dosage for atrial fibrillation ablation in patients receiving non-vitamin K antagonist oral anticoagulants","volume":"36","author":"Yamaji","year":"2016","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.hroo.2026.05.023_bib10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/clc.23681","article-title":"Differences in activated clotting time and total unfractionated heparin dose during pulmonary vein isolation in patients on different anticoagulation therapy","volume":"44","author":"Zeljkovic","year":"2021","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hroo.2026.05.023_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/europace\/euz057","article-title":"Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study","volume":"21","author":"Calkins","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.05.023_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10840-019-00579-y","article-title":"Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation","volume":"58","author":"Payne","year":"2020","journal-title":"Interv Card Electrophysiol"},{"key":"10.1016\/j.hroo.2026.05.023_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cvdhj.2023.11.001","article-title":"Evaluation of an adaptive, rule-based dosing algorithm to maintain therapeutic anticoagulation during atrial fibrillation ablation","volume":"4","author":"Kalscheur","year":"2023","journal-title":"Cardiovasc Digit Health J"},{"key":"10.1016\/j.hroo.2026.05.023_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00380-018-1294-2","article-title":"A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants","volume":"34","author":"Kishima","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hroo.2026.05.023_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jce.14892","article-title":"Protocol driven periprocedural anticoagulation for left atrial ablation","volume":"32","author":"Bradley","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2026.05.023_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1074248421998492","article-title":"Comprehensive intraprocedural unfractionated heparin protocol during catheter ablation of atrial fibrillation in the presence of direct oral anticoagulants and wide spectrum of body mass index","volume":"26","author":"Michael","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hroo.2026.05.023_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-5223(19)41500-6","article-title":"Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage","volume":"69","author":"Bull","year":"1975","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hroo.2026.05.023_bib18","first-page":"29","article-title":"A novel method for calculating heparin dosing to rapidly achieve target anticoagulation for cardiac procedures","volume":"17","author":"Cumpston","year":"2024","journal-title":"J Atr Fibrillation Electrophysiol"},{"key":"10.1016\/j.hroo.2026.05.023_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejvs.2022.08.005","article-title":"Editor's choice - sex differences in response to administration of heparin during non-cardiac arterial procedures","volume":"64","author":"Roosendaal","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.hroo.2026.05.023_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ajh.21751","article-title":"Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparin","volume":"85","author":"Verma","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hroo.2026.05.023_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/j.1875-9114.1998.tb03140.x","article-title":"In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone","volume":"18","author":"Rosborough","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.hroo.2026.05.023_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MAJ.0b013e318063c707","article-title":"The importance of correct norms in blood volume measurement","volume":"334","author":"Feldschuh","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.hroo.2026.05.023_bib23","first-page":"224","article-title":"Prediction of blood volume in normal human adults","volume":"51","author":"Nadler","year":"1962","journal-title":"Surgery"},{"key":"10.1016\/j.hroo.2026.05.023_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12871-019-0846-z","article-title":"Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability","volume":"19","author":"Dirkmann","year":"2019","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.hroo.2026.05.023_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00000542-199910000-00031","article-title":"Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques","volume":"91","author":"Despotis","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.hroo.2026.05.023_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0003-4975(10)63396-6","article-title":"Use of activated coagulation time to monitor heparin during cardiac surgery","volume":"28","author":"Roth","year":"1979","journal-title":"Ann Thorac Surg"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826002497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826002497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:22:02Z","timestamp":1789723322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501826002497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666501826002497"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2026.05.023","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized dose\u2013response algorithm vs weight-based heparin dosing for intraprocedural anticoagulation during atrial fibrillation ablation","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2026.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}